Study of Genetic Differences in People With Depression (Genetics)
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Andrew F. Leuchter, University of California, Los Angeles
First received: September 28, 2005
Last updated: July 1, 2014
Last verified: July 2014
The purpose of this study is to identify genes involved in depression. Specifically, the investigators will analyze some genes that may be related to whether or not a person responds to antidepressant medication. This project is part of basic scientific research to increase understanding of the role of genetic influences in psychological and mental processes involved in the response to treatment for depression.
Depressive Disorder, Major
||Observational Model: Case Control
Time Perspective: Cross-Sectional
||Study of Genetic Differences in People With Depression
| Estimated Enrollment:
| Study Start Date:
|Ages Eligible for Study:
||18 Years to 75 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients will be recruited from previous studies conducted at the Laboratory of Brain, Behavior, and Pharmacology, where subjects' response to treatment has already been determined. This strategy offers the advantage that no new subjects need to be enrolled in placebo-controlled treatment studies.
- History of Unipolar Major Depression
- Control subjects must be healthy normal adults
- Subjects with mood symptoms that are not severe enough to qualify for MDD
- Subjects with any active medical illness that may be related to ongoing mood disorder
- Normal subjects must be free from: a psychiatric diagnosis, substance abuse, a history of seizure disorder, and any serious medical illness
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229463
|UCLA Semel Institute for Neuroscience and Human Behavior
|Los Angeles, California, United States, 90024 |
University of California, Los Angeles
||Andrew F. Leuchter, M.D.
||University of California, Los Angeles
No publications provided
||Andrew F. Leuchter, Principal Investigator, University of California, Los Angeles
History of Changes
|Other Study ID Numbers:
|Study First Received:
||September 28, 2005
||July 1, 2014
||United States: Institutional Review Board
Keywords provided by University of California, Los Angeles:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on July 31, 2014
Depressive Disorder, Major